Matricelf
Personalized Platform for Autologous Regenerative Medicine
Active
Public
Startup
Ness Ziona
Founded 2019-04
Matricelf has developed a technology that enables the production of autologous engineered tissue composed of matrix and cells derived from patients omental biopsies. In 2019, Matricelf licensed the technology that enabled scientists at Tel Aviv university to 3D print a human heart from human cells and matrix for the first time in history. Matricelfs proprie…
SectorHealth Tech & Life Sciences
StagePublic
Total raised$10.0M
Employees16
Founded2019-04
HQNess Ziona
Patents1
Confidence99
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Technology
Materials & SubstancesImplantsBiologicalsCells
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesBiotechnologyPharmaceuticals